Development and validation of 3‐CpG methylation prognostic signature based on different survival indicators for colorectal cancer

2021 ◽  
Author(s):  
Hao Huang ◽  
Lei Zhang ◽  
Jinming Fu ◽  
Tian Tian ◽  
Xinyan Liu ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cpg Methylation ◽  
Prognostic Signature ◽  
Development And Validation

scholarly journals Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer

2021 ◽  
Vol 9 (9) ◽  
pp. 747-747
Author(s):  
Junlan Feng ◽  
Qing Wei ◽  
Muqing Yang ◽  
Xiaodong Wang ◽  
Bin Liu ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Stage Ii ◽  
Prognostic Signature ◽  
Novel Mirna ◽  
Development And Validation

Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer

2021 ◽  
Author(s):  
Xiao-Cheng Wang ◽  
Ya Liu ◽  
Fei-Wu Long ◽  
Liang-Ren Liu ◽  
Chuan-Wen Fan
Keyword(s):  
Colorectal Cancer ◽  
Overall Survival ◽  
Prognostic Markers ◽  
The Cancer Genome Atlas ◽  
Prognostic Signature ◽  
Free Survival ◽  
Cancer Genome Atlas ◽  
Bioinformatic Approaches ◽  
Cell Phenotypes ◽  
The Relationship

Background: The relationship between long noncoding RNAs (lncRNAs) and the mRNA stemness index (mRNAsi) in colorectal cancer (CRC) is still unclear. Materials & methods: The mRNAsi, mRNAsi-related lncRNAs and their clinical significance were analyzed by bioinformatic approaches in The Cancer Genome Atlas (TCGA)-COREAD dataset. Results: mRNAsi was negatively related to pathological features but positively related to overall survival and recurrence-free survival in CRC. A five mRNAsi-related lncRNAs prognostic signature was further developed and showed independent prognostic factors related to overall survival in CRC patients, due to the five mRNAsi-related lncRNAs involved in several pathways of the cancer stem cells and malignant cancer cell phenotypes. Conclusion: The present study highlights the potential roles of mRNAsi-related lncRNAs as alternative prognostic markers.

scholarly journals Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma

2019 ◽  
Vol 9 ◽  
Author(s):  
Xiangyang Deng ◽  
Dongdong Lin ◽  
Bo Chen ◽  
Xiaojia Zhang ◽  
Xingxing Xu ◽  
...  
Keyword(s):  
Lower Grade ◽  
Prognostic Signature ◽  
Lower Grade Glioma ◽  
Development And Validation

scholarly journals Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma

2019 ◽  
Vol 8 ◽  
Author(s):  
Xiao-Ping Liu ◽  
Xiao-Hong Yin ◽  
Xiang-Yu Meng ◽  
Xin-Hui Yan ◽  
Fan Wang ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Prognostic Signature ◽  
Development And Validation

scholarly journals Development and validation of an immune-related gene pairs signature in colorectal cancer

2019 ◽  
Vol 8 (7) ◽  
pp. e1596715 ◽  
Author(s):  
Jianping Wu ◽  
Ying Zhao ◽  
Juanwen Zhang ◽  
Qianxia Wu ◽  
Weilin Wang
Keyword(s):  
Colorectal Cancer ◽  
Related Gene ◽  
Gene Pairs ◽  
Immune Related Gene ◽  
Development And Validation

Identification and validation of an immune prognostic signature in colorectal cancer

2020 ◽  
Vol 88 ◽  
pp. 106868
Author(s):  
Mengting Li ◽  
Haizhou Wang ◽  
Wenjie Li ◽  
Yanan Peng ◽  
Fei Xu ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Prognostic Signature

External validation of a tumor derived 5-gene prognostic signature (OncoDefender-CRC) for recurrence (R) of stages I/II colorectal cancer (CRC).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 3559-3559
Author(s):  
P. F. Lenehan ◽  
L. A. Boardman ◽  
D. W. Fry ◽  
E. R. Heyman ◽  
J. Ohrnberger ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
External Validation ◽  
Prognostic Signature
Sign in / Sign up

Export Citation Format

Share Document